Colon cancer is a world concerning disease; it shows a high mortality rate and may be related to eating habits. Studies using inulin-like fructans, which are produced as energy supplies by several plants, have demonstrated a chemo-protective effect of these fructans in colon cancer. However, agavins a structurally different type of fructans from the Agave genus with demonstrated prebiotic effects, have been poorly studied for their possible protective effects in cancer. The aim of the present study was to evaluate the effect of Agave fructan-rich diets in colon cancer progress using a rat model and "Agave mezcalero potosino" A. salmiana Otto ex Salm Dick, which is widely distributed in Mexico. Results showed a significant decrease (p<0.05) in early lesions of colon cancer (aberrant crypt foci) compared with the control group. These data suggest that fructans from A. salmiana may contribute to a reduction in the risk of colon cancer as well as inulin-like compounds.
Colon cancer produces 650,000 deaths per year worldwide [1] and is one of the most common causes of cancer-related deaths in the world [1, 2] , especially in industrialized countries [3] . Colon health has been related to the presence of different molecules in the intestinal lumen. Fructans are rich substrates for the fermentative processes of several bacterial strains living in the human intestinal tract, such as Lactobacillus and Bifidobacterium spp., which have been associated with improved health [4] . Fructans are fructose polysaccharides with (2-1) glycosidic bonds [5] that function as the main reserve carbohydrates in several plant species [6] . These molecules have been shown to produce a prebiotic effect in several studies [6] [7] [8] [9] [10] . Fructan breakdown produces short-chain fatty acids (SCFA) such as acetic, propionic and butyric acids [5] that have important effects in human metabolism [4, 10] . Short-chain fatty acids, especially butyrate, promote the growth of lactobacilli and bifidobacteria and are very important in the physiology and metabolism of the colon as the major source of energy for colonocytes [11] . Butyrate has been reported to be involved in several intestinal functions [12] and is known for its possible action on secondary chemoprevention by decelerating growth and triggering apoptosis in colon cancer cells [13, 14] . A property of butyrate related to its direct effects is the capacity of inhibition of the histone deacetylases, resulting in a set of cell functions including gene regulation, cancer suppression, immune modulation, cell differentiation, diarrhea control, oxidative stress reduction, intestinal barrier regulation, visceral sensitivity and intestinal motility modulation. Therefore, butyrate is a key factor for intestinal health [15] .
Inulin-type fructans from Chichorium intybus have a chemoprotective effect and contribute to colorectal cancer risk reduction [16] .
Fructans from C. intybus comprise linear molecules containing only 2, 1-linked fructosyl chains, terminal glucose and terminal fructose [17, 18] . Agave genus fructans, known as agavins, are composed of a complex mixture of highly branched molecules, with β (2-1) linkages mainly, but also some β (2-6), as well as internal and external glucose units [18] [19] [20] . Based on the wellbeing benefits of fructans, there is an increasing interest in the agavins potential health benefits. A. salmiana Otto ex Salm Dick is a native species highly distributed in Mexico. In this Agave type, fructans represent up to 20% of the dry weight and they satisfy the metabolic and reproductive energy demand of the plant [18, 21] .The aim of the present study was to evaluate the protective effect of the administration of A. salmiana fructans in an azoxymethane induced carcinogenesis animal model, using Aberrant Crypt Foci (ACF) bioassays a predictor for the development of colorectal cancer [5, 22] .
The prebiotic effect consists of stimulation of growth of one or some specific bacterial strain(s) that confer health benefits to the host [25] . Figure 1A shows that lactobacilli colonies in healthy (14.4 Ln lactobacilli CFU/g feces) and cancer-induced rats (14.7 Ln lactobacilli CFU/g feces) were similar. The statistical analysis indicated that the lactobacilli amount depends on the food type and the health of the animals (p<0.0001). The increase in beneficial bacteria was higher in groups consuming C. intybus fructans (16.5 Ln lactobacilli CFU/g feces) compared with the A. salmiana groups (13.4 Ln lactobacilli CFU/g feces), as we previously reported for a different Agave species [26] .
Micro environmental pH in the colon has been reported [8, 10, 13, 18] to decrease with fructan rich diets in both in vitro and in vivo models. In this work, feces pH was influenced by the food source (p<0.0001) and not by the health of the animals (p<0.0001). Figure  1B shows that feces pH decreases significantly in rats fed with fructans compared with those fed with regular food. In the healthy and AOM-induced groups fed with Agave and Chichorium the final feces pH was not significantly different (p=0.17 and p=0.72 respectively). A change in colonic pH is related to the short-chain fatty acids profile [27] [28] [29] [30] , mainly in the increase of colonic concentrations of butyrate, which is an important mediator in the chemo-protective effect [31] [32] [33] . Several investigations reported that inulin-type fructans reduce the aberrant crypt focus [5, 8, 10, 33 and 34] and hence decrease the risk of colon cancer. In this work, similar outcomes with Agave fructans were found. As expected, healthy rats did not show ACF ( Figure 2) . Figure 3 shows the number of aberrant crypt focus found in the complete colon of AOM-treated and control rats. A significant decrease in ACF in groups fed with Agave fructans compared with the control group was observed (p<0.05). The decrease was almost 3 times bigger in rats fed with Chichorium fructans (positive control). This suggests chemo-protective effects for A. salmiana fructans and C. intybus, although the beneficial effects of C. intybus were higher (p≤0.05) than those of A. salmiana. These results may be due to the structural differences between the two types of fructans, as agavins have multiple branching. Also, the purity of the fructan source may be playing a role in the outcomes, since the industrial purification process of C. intybus fructans ensures only 10% of impurities and in the A. salmiana fructans the purity was not determined. Purifying the extracts from A. salmiana would be necessary in order to compare the observed results.
Inulin type fructans have been widely reported to decrease the risk of colon cancer. This is, to our knowledge, the first report on the chemo-protective effects of A. salmiana fructans Despite the structural differences between Chichorium and Agave fructans, the positive effect of the latter in the decrease of early markers of colon cancer (ACF) was established. Purified fructans from this Agave species should be tested in vivo for confirmation of these results. Further research needs to be conducted into the potential uses of A. salmiana fructans as prebiotics and chemoprotective compounds.
Experimental
Fructan sources: Four Agave salmiana Otto ex Salm Dick plants were collected in the community of Charcas, in the State of San Luis Potosí, México. Fructans were obtained using the procedure of López et al. [23] . Commercially available chicory (Chichorium intybus) fructans (Sigma) were used as a positive control.
Animals: Animals were provided by the Centro de Biociencias of the Universidad Autónoma de San Luis Potosí, S.L.P, México. Six week old Wistar rats (n=36) were fed with conventional rodent diet (Harlan® 5001, USA) and water ad libitum during the adaptation phase. In the control group, the diet remained the same throughout the experiment. Other groups of animals received an optimized 1:10 proportion of either A. salmiana or C. fructans mixed with the conventional food ad libitum [10] . The experimental design was a 2x3 factorial display including healthy and cancer-induced groups with fructan supply as variables.
Carcinogenesis induction:
One week after the change in diet 15mg/kg of azoxymethane (AOM; 13.4 M Sigma Aldrich®, USA) diluted in saline solution was administrated intraperitoneally (IP). This treatment was repeated once with a one week interval. The healthy groups received only saline solution in both treatments.
Microbiological assay: After 12 weeks of the second AOM dosage, feces were analyzed for microbes using the Miles Misra Irwin protocol to quantify the lactobacilli colony forming units (CFU). Samples were incubated in anaerobic conditions in Man Rogosa Sharpe medium (Difco®, USA) at 37°C for 48 h.
Feces pH:
Feces were dispersed in water as a 10%, w/v, suspension, and pH was measured with a glass electrode potentiometer (Hanna Instruments® pH211, USA).
Chemo-protective effect:
Thirteen weeks after the second AOM administration all the animals were euthanized according to local bioethics guidelines. After dissection, the colon was cut out in 1cm long segments and fixed in 10% p-formaldehyde for 24 h. Tissues were included in paraffin blocks and cut in longitudinal 3 m slides. Slides were stained with the Harris stain protocol [23] . Direct bright field microscopy was used to count the ACF (containing at least 2 aberrant crypts) with a 40X objective (Celestron® Ddi 44108, USA) in the complete colon of healthy and cancer-induced rats.
Data processing: Data were analyzed as a randomized complete design, within a factorial arrangement of treatments 2 (health status) x 3 (fructan source). Main effects means and interactions were analyzed using the mixed option of statistics package SAS [24] . When an interaction was observed (p≤0.05), the SLICE option of SAS was used to evaluate it. Lactobacilli CFU/g were transformed to natural logarithm Ln values and analyzed with the same model. The Shapiro-Wilk test was used to calculate the normal distribution of ACF/colon. The U Mann Whitney test was used to compare group results.
